Joseph Carleone - 03 Nov 2025 Form 4 Insider Report for SENSIENT TECHNOLOGIES CORP (SXT)

Role
Director
Signature
/s/ John J. Manning, Attorney-in-Fact for Dr. Carleone
Issuer symbol
SXT
Transactions as of
03 Nov 2025
Net transactions value
+$91,258
Form type
4
Filing time
03 Nov 2025, 16:27:30 UTC
Previous filing
01 Oct 2025
Next filing
02 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Carleone Joseph Director 777 EAST WISCONSIN AVENUE, MILWAUKEE /s/ John J. Manning, Attorney-in-Fact for Dr. Carleone 03 Nov 2025 0001212515

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SXT Common Stock Purchase $91,258 +1,000 +4.7% $91.26 22,414 03 Nov 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding SXT Deferred Stock 22,777 03 Nov 2025 Common Stock 22,777 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.
F2 Deferred stock converts to common stock on a one-for-one basis.
F3 Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.